Terms: = Ovarian cancer AND EIF4A2, DDX2B, 1974, ENSG00000156976, EIF4F, BM-010, EIF4A AND Diagnosis
29 results:
1. Predictive factors of recurrence in patients with early-stage epithelial ovarian cancer.
Ditto A; Leone Roberti Maggiore U; Bogani G; Martinelli F; Chiappa V; Evangelista MT; Liberale V; Ferrero S; Raspagliesi F
Int J Gynaecol Obstet; 2019 Apr; 145(1):28-33. PubMed ID: 30698271
[TBL] [Abstract] [Full Text] [Related]
2. Primary extra-uterine and extra-ovarian mullerian adenosarcoma: case report and literature review.
Mandato VD; Torricelli F; Mastrofilippo V; Valli R; Aguzzoli L; La Sala GB
BMC Cancer; 2018 Feb; 18(1):134. PubMed ID: 29402239
[TBL] [Abstract] [Full Text] [Related]
3. Fertility treatments among female cancer survivors giving birth - a Finnish register-based study.
Melin J; Madanat-Harjuoja L; Heinävaara S; Malila N; Gissler M; Tiitinen A
Acta Oncol; 2017 Aug; 56(8):1089-1093. PubMed ID: 28339338
[TBL] [Abstract] [Full Text] [Related]
4. Intraperitoneal chemotherapy for the initial management of primary epithelial ovarian cancer.
Jaaback K; Johnson N; Lawrie TA
Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD005340. PubMed ID: 26755441
[TBL] [Abstract] [Full Text] [Related]
5. Tau protein as a potential predictive marker in epithelial ovarian cancer patients treated with paclitaxel/platinum first-line chemotherapy.
Smoter M; Bodnar L; Grala B; Stec R; Zieniuk K; Kozlowski W; Szczylik C
J Exp Clin Cancer Res; 2013 Apr; 32(1):25. PubMed ID: 23631819
[TBL] [Abstract] [Full Text] [Related]
6. Diagnostic value of HE4 for ovarian cancer: a meta-analysis.
Yu S; Yang HJ; Xie SQ; Bao YX
Clin Chem Lab Med; 2012 Feb; 50(8):1439-46. PubMed ID: 22868811
[TBL] [Abstract] [Full Text] [Related]
7. Intraperitoneal chemotherapy for the initial management of primary epithelial ovarian cancer.
Jaaback K; Johnson N; Lawrie TA
Cochrane Database Syst Rev; 2011 Nov; (11):CD005340. PubMed ID: 22071822
[TBL] [Abstract] [Full Text] [Related]
8. Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality.
Domchek SM; Friebel TM; Singer CF; Evans DG; Lynch HT; Isaacs C; Garber JE; Neuhausen SL; Matloff E; Eeles R; Pichert G; Van t'veer L; Tung N; Weitzel JN; Couch FJ; Rubinstein WS; Ganz PA; Daly MB; Olopade OI; Tomlinson G; Schildkraut J; Blum JL; Rebbeck TR
JAMA; 2010 Sep; 304(9):967-75. PubMed ID: 20810374
[TBL] [Abstract] [Full Text] [Related]
9. Predictors of recurrence of ovarian granulosa cell tumors.
Nosov V; Silva I; Tavassoli F; Adamyan L; Farias-Eisner R; Schwartz PE
Int J Gynecol Cancer; 2009 May; 19(4):628-33. PubMed ID: 19509561
[TBL] [Abstract] [Full Text] [Related]
10. Marriage after cancer in older adulthood.
Syse A; Aas GB
J Cancer Surviv; 2009 Mar; 3(1):66-71. PubMed ID: 19148756
[TBL] [Abstract] [Full Text] [Related]
11. Epidemiological aspects of ovarian malignancies in North Sardinia in the period 1992-2001.
Cossu A; Budroni M; Capobianco G; Pirino D; Palmieri G; Dessole S; Tanda F; Cesaraccio R; Cherchi PL
Eur J Gynaecol Oncol; 2005; 26(1):47-50. PubMed ID: 15755000
[TBL] [Abstract] [Full Text] [Related]
12. Associated primary tumors in patients with gastric cancer.
Dinis-Ribeiro M; Lomba-Viana H; Silva R; Moreira-Dias L; Lomba-Viana R
J Clin Gastroenterol; 2002; 34(5):533-5. PubMed ID: 11960064
[TBL] [Abstract] [Full Text] [Related]
13. Should we colonoscope women with gynecologic cancer?
Rex D
Am J Gastroenterol; 2000 Mar; 95(3):812-3. PubMed ID: 10710083
[TBL] [Abstract] [Full Text] [Related]
14. The epidemiology of ovarian cancer: a population-based study in Olmsted County, Minnesota, 1935-1991.
Beard CM; Hartmann LC; Atkinson EJ; O'Brien PC; Malkasian GD; Keeney GL; Melton LJ
Ann Epidemiol; 2000 Jan; 10(1):14-23. PubMed ID: 10658685
[TBL] [Abstract] [Full Text] [Related]
15. Risk for colorectal cancer after gynecologic cancer.
Weinberg DS; Newschaffer CJ; Topham A
Ann Intern Med; 1999 Aug; 131(3):189-93. PubMed ID: 10428735
[TBL] [Abstract] [Full Text] [Related]
16. Systematic pelvic and paraaortic lymphadenectomy at second-look laparotomy for ovarian cancer.
Baiocchi G; Grosso G; di Re E; Fontanelli R; Raspagliesi F; di Re F
Gynecol Oncol; 1998 May; 69(2):151-6. PubMed ID: 9600823
[TBL] [Abstract] [Full Text] [Related]
17. Malignant mixed mesodermal ovarian tumor treatment and prognosis: a 20-year experience.
Le T; Krepart GV; Lotocki RJ; Heywood MS
Gynecol Oncol; 1997 May; 65(2):237-40. PubMed ID: 9159331
[TBL] [Abstract] [Full Text] [Related]
18. Prospective study of serum CA-125 levels as markers of ovarian cancer.
Helzlsouer KJ; Bush TL; Alberg AJ; Bass KM; Zacur H; Comstock GW
JAMA; 1993 Mar; 269(9):1123-6. PubMed ID: 8433467
[TBL] [Abstract] [Full Text] [Related]
19. Benign ovarian cysts in England and Wales and in the United States.
Westhoff C; Clark CJ
Br J Obstet Gynaecol; 1992 Apr; 99(4):329-32. PubMed ID: 1581280
[TBL] [Abstract] [Full Text] [Related]
20. [Periodical changes in diagnosis and treatment of ovarian tumors].
Ohta M
Rinsho Byori; 1992 Feb; 40(2):106-12. PubMed ID: 1583782
[TBL] [Abstract] [Full Text] [Related]
[Next]
